Recruiting NA Respiratory Distress Syndrome

New treatment option for Respiratory Distress Syndrome

Official title Effect of Postural Drainage With or Without Thoracic Squeezing on O2 and Respiratory Rate in Infant With RDS.

ClinicalTrials.gov ID: NCT07579013

What this study is testing

What it's testing
This study investigated whether adding thoracic squeezing to postural drainage improves immediate respiratory outcomes in preterm infants with Respiratory Distress Syndrome (RDS). Over nine months, 14 preterm infants (all born via cesarean section) were randomly assigned to two groups.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 1 to 2

You may be able to join if

  • ● Children diagnosed with RDS.
  • Pre term infants. Birth history with c- section.
  • No congenital malformation.

You likely can't join if

  • ● Under treatment with neurotropic drugs.
  • Respiratory and cardiac congenital anamolies.
  • Genetic disorder.
  • Interventricular hemorrhage or seizures.

The study team makes the final eligibility decision.

Where it's taking place

  • Lahore, Punjab Province, Pakistan

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 1 month to 2 months. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Lahore, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.